4//SEC Filing
ROCAMBOLI STEPHEN 4
Accession 0001628280-22-015582
CIK 0001434868other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:13 PM ET
Size
11.5 KB
Accession
0001628280-22-015582
Insider Transaction Report
Form 4
ROCAMBOLI STEPHEN
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-26+1,589→ 1,589 totalExercise: $5.51Exp: 2032-05-26→ Common Stock (1,589 underlying) - Award
Stock Option (right to buy)
2022-05-26+40,000→ 40,000 totalExercise: $5.51Exp: 2032-05-26→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The awards vest over a three (3) year period in equal annual installments, the first of which will be May 26, 2023.
- [F2]The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001221451
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:13 PM ET
- Size
- 11.5 KB